Z

Jin Medical International Ltd.

ZJYL Nasdaq Healthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies Jiangsu Province, China www.zhjmedical.com
$1.97
Mkt Cap 308.4M
On January 26, 2006, the VIE, Changzhou Zhongjin, was formed pursuant to PRC law as a limited company. We operate our wheelchair and living aids product design and manufacture business through Changzh…

On January 26, 2006, the VIE, Changzhou Zhongjin, was formed pursuant to PRC law as a limited company. We operate our wheelchair and living aids product design and manufacture business through Changzhou Zhongjin and its wholly owned subsidiaries, Zhongjin Taizhou and Zhongjin Jing’ao Trading, in China. On June 17, 2013, Zhongjin Taizhou was formed pursuant to PRC law as a limited company. On December 18, 2014, Zhongjin Jing’ao was formed pursuant to PRC law as a limited company. On January 14, 2020, Jin Med, an exempted company limited by shares, was incorporated under Cayman Islands law pursuant to the Companies Act (As Revised) of the Cayman Islands as a holding company. The address and telephone number of Jin Med is No. 33 Lingxiang Road, Wujin District, Changzhou City, Jiangsu Province, People’s Republic of China, +86-519 89607972 On February 25, 2020, Zhongjin HK, a holding company, was formed in Hong Kong, which owns 100% shares of Erhua Med, or WFOE, which was formed on September 24, 2020 as a limited company pursuant to PRC law. On March 30, 2023, the Company closed its initial public offering ( IPO ) of 1,000,000 Ordinary Shares, pursuant to its registration statement on Form F-1 (File No.333-259767), which was declared effective by the SEC on March 27, 2023. The Ordinary Shares were priced at $8.00 per share and the IPO was conducted on a firm commitment basis. The Ordinary Shares commenced trading under the symbol ZJYL on the Nasdaq Capital Market on March 28, 2023.

/100 Overall
Calculating score…
Running full analysis
📊 Key Metrics
Loading full analysis…
REVENUE TTM
$20.7M
FCF TTM
-$3.7M
P/E RATIO
258.9x
Running full 6-factor analysis…